| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cellular Biology |
From the Department of Regenerative Medicine (H.M., M.Y., M.W., M.K., R.I., H.I., M.E., Y.I., R.T., Y.N., A.S., S.N., S.K., T.A.), Tokai University School of Medicine, Isehara, Japan; the Department of Vascular Medicine (C.K.), Swiss Cardiovascular Center, University Hospital of Bern, Switzerland; the third Department of Internal Medicine (T.T.), Tokyo Medical University, Japan; the Department of Cell Signaling (S.H.), Gifu University Graduate School of Medicine, Japan.; Stem Cell Translational Research (T.A.), Institute of Biomedical Research and Innovation/ RIKEN Center for Developmental Biology, Kobe, Japan.
Correspondence to Takayuki Asahara, MD, PhD, Department of Regenerative Medicine, Tokai University School of Medicine, Bohseidai, Isehara, Kanagawa 259-1193, Japan. E-mail asa777{at}aol.com
Estrogen has been demonstrated to promote therapeutic reendothelialization after vascular injury by bone marrow (BM)–derived endothelial progenitor cell (EPC) mobilization and phenotypic modulation. We investigated the primary hypothesis that estrogen regulates physiological postnatal vasculogenesis by modulating bioactivity of BM-derived EPCs through the estrogen receptor (ER), in cyclic hormonally regulated endometrial neovascularization. Cultured human EPCs from peripheral blood mononuclear cells (PB-MNCs) disclosed consistent gene expression of ER
as well as downregulated gene expressions of ER ß. Under the physiological concentrations of estrogen (17ß-estradiol, E2), proliferation and migration were stimulated, whereas apoptosis was inhibited on day 7 cultured EPCs. These estrogen-induced activities were blocked by the receptor antagonist, ICI182,780 (ICI). In BM transplanted (BMT) mice with ovariectomy (OVX) from transgenic mice overexpressing ß-galactosidase (lacZ) regulated by an endothelial specific Tie-2 promoter (Tie-2/lacZ/BM), the uterus demonstrated a significant increase in BM-derived EPCs (lacZ expressing cells) incorporated into neovasculatures detected by CD31 immunohistochemistry after E2 administration. The BM-derived EPCs that were incorporated into the uterus dominantly expressed ER
, rather than ER ß in BMT mice from BM of transgenic mice overexpressing EGFP regulated by Tie-2 promoter with OVX (Tie-2/EGFP/BMT/OVX) by ERs fluorescence immunohistochemistry. An in vitro assay for colony forming activity as well as flow cytometry for CD133, CD34, KDR, and VE-cadherin, using human PB-MNCs at 5 stages of the female menstrual-cycle (early-proliferative, pre-ovulatory, post-ovulatory, mid-luteal, late-luteal), revealed cycle-specific regulation of EPC kinetics. These findings demonstrate that physiological postnatal vasculogenesis involves cyclic, E2-regulated bioactivity of BM-derived EPCs, predominantly through the ER
.
Key Words: estrogen endothelial progenitor cell estrogen receptor physiological postnatal vasculogenesis
This article has been cited by other articles:
![]() |
J. E Girling and P. A W Rogers Regulation of endometrial vascular remodelling: role of the vascular endothelial growth factor family and the angiopoietin-TIE signalling system Reproduction, December 1, 2009; 138(6): 883 - 893. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Sussman Showing up Isn't Enough for Vascularization: Persistence Is Essential Circ. Res., November 21, 2008; 103(11): 1200 - 1201. [Full Text] [PDF] |
||||
![]() |
I. Spyridopoulos, S. Fichtlscherer, R. Popp, S. W. Toennes, B. Fisslthaler, T. Trepels, A. Zernecke, E. A. Liehn, C. Weber, A. M. Zeiher, et al. Caffeine Enhances Endothelial Repair by an AMPK-Dependent Mechanism Arterioscler Thromb Vasc Biol, November 1, 2008; 28(11): 1967 - 1974. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. M. Miller and S. P. Duckles Vascular Actions of Estrogens: Functional Implications Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Fadini, S. de Kreutzenberg, M. Albiero, A. Coracina, E. Pagnin, I. Baesso, A. Cignarella, C. Bolego, M. Plebani, G. B. Nardelli, et al. Gender Differences in Endothelial Progenitor Cells and Cardiovascular Risk Profile: The Role of Female Estrogens Arterioscler Thromb Vasc Biol, May 1, 2008; 28(5): 997 - 1004. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Nelson, A. G. Zenovich, H. C. Ott, C. Stolen, G. J. Caron, A. Panoskaltsis-Mortari, S. A. Barnes III, X. Xin, and D. A. Taylor Sex-Dependent Attenuation of Plaque Growth After Treatment With Bone Marrow Mononuclear Cells Circ. Res., December 7, 2007; 101(12): 1319 - 1327. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |